核医学の世界市場2015-2022...市場調査レポートについてご紹介

【英文タイトル】Nuclear Medicine - Global Market Outlook (2015-2022)

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Nuclear Medicine Market, By Application
5.1 Introduction
5.2 Therapeutics
5.2.1 Bone Metastasis
5.2.2 Endocrine Tumors
5.2.3 Lymphoma
5.2.4 Thyroid
5.2.5 Nephrology
5.2.6 Cardiology
5.2.7 Neurology
5.2.8 Other Therapeutic Applications
5.3 Diagnostics
5.3.1 Positron Emission Tomography (PET)
5.3.1.1 Oncology
5.3.1.2 Neurology
5.3.1.3 Cardiology
5.3.1.4 Inflammation
5.3.1.5 Other PET Applications
5.3.2 Single Photon Emission Computed Tomography (SPECT)
5.3.2.1 Thyroid
5.3.2.2 Neurology
5.3.2.3 Lymphoma
5.3.2.4 Cardiology
5.3.2.5 Gastro Intestinal
5.3.2.6 Oncology
5.3.2.7 Nephrology
5.3.2.8 Inflammation
5.3.2.5 Other Diagnostic Applications

6 Global Nuclear Medicine Market, By Type
6.1 Introduction
6.2 Nuclear Medicine Therapeutic Isotopes
6.2.1 Alpha Emitters
6.2.1.1 Thorium-227 (Th-227)
6.2.1.2 Radium-224
6.2.1.3 Radium-223
6.2.1.4 Lead (Pb-212)/Bismuth (Bi-212)
6.2.1.5 Astatine (At-211)
6.2.1.6 Actinium (Ac-225)
6.2.1.7 Others
6.2.2 Brachytherapy
6.2.2.1 Palladium-103
6.2.2.2 Iridium-192
6.2.2.3 Iodine-125
6.2.2.4 Cesium-131
6.2.2.5 Others
6.2.3 Beta Emitters
6.2.3.1 Yttrium-90 (Y-90)
6.2.3.2 Samarium-153 (SM-153)
6.2.3.3 Rhenium-186 (Re-186)
6.2.3.4 Lutetium-177 (Lu-177)
6.2.3.5 Iodine-131 (I-131)
6.2.3.6 Erbium (Er-169)
6.2.3.7 Strontium (Sr-89)
6.2.3.8 Others
6.3 Nuclear Medicine/Radiopharmaceuticals Diagnostics
6.3.1 Positron Emission Tomography (PET) Radiopharmaceuticals
6.3.1.1 Rubidium-82 (RB-82)
6.3.1.2 Fluorodeoxyglucose (FDG)
6.3.1.3 Gallium (Ga-68)
6.3.1.4 Others
6.3.2 Single Photon Emission Computed Tomography (SPECT)
6.3.2.1 Technetium-99m (TC-99m)
6.3.2.2 Thallium-201 (TL-201)
6.3.2.3 Gallium-67 (GA-67)
6.3.2.4 Iodine (I-123)
6.3.2.5 Samarium
6.3.2.6 Yttrium
6.3.2.7 Rhenium
6.3.2.8 Others

7 Global Nuclear Medicine Market, By Procedural Volume
7.1 Introduction
7.2 Therapeutic
7.2.1 Alpha Emitters
7.2.2 Beta Emitters
7.2.3 Brachytherapy
7.3 Diagnostics
7.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
7.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals

8 Global Nuclear Medicine Market, By End User
8.1 Introduction
8.2 Academic Research Laboratories
8.3 Industries
8.4 Medical
8.4.1 Hospitals
8.4.2 Diagnostic Centers

9 Global Nuclear Medicine Market, By Stable Isotope
9.1 Introduction
9.2 Sulphur (S-32)
9.3 Oxygen (O-18)
9.4 Nitrogen (N-15)
9.5 Deuterium (D2)
9.6 Carbon (C-13)
9.7 Other Stable Isotopes

10 Global Nuclear Medicine Market, By Geography
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Advanced Accelerator Applications S.A.
12.2 Ashby Gorman Baker Ltd,
12.3 Bayer Healthcare
12.4 Bracco Imaging S.P.A
12.5 Cardinal Health
12.6 Digirad
12.7 Eczcibasi-Monrol Nuclear Products
12.8 GE Healthcare
12.9 IBA Molecular Imaging
12.10 Lantheus Medical Imaging
12.11 Mallinckrodt PLC
12.12 Mediso Ltd.
12.13 Nordion, Inc.
12.14 Philips Healthcare
12.15 Siemens Healthcare

Table of Contents
1 Global Nuclear Medicine Market Outlook, By Region (2013-2022) ($MN)
2 Global Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
3 Global Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
4 Global Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
5 Global Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
6 Global Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
7 Global Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
8 Global Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
9 Global Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
10 Global Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
11 Global Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
12 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
13 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
14 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
15 Global Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
16 Global Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
17 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
18 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
19 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
20 Global Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
21 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
22 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
23 Global Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
24 Global Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
25 Global Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
26 Global Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
27 Global Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
28 Global Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
29 Global Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
30 Global Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
31 Global Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
32 Global Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
33 Global Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
34 Global Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
35 Global Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
36 Global Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
37 Global Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
38 Global Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
39 Global Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
40 Global Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
41 Global Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
42 Global Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
43 Global Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
44 North America Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
45 North America Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
46 North America Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
47 North America Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
48 North America Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
49 North America Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
50 North America Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
51 North America Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
52 North America Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
53 North America Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
54 North America Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
55 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
56 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
57 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
58 North America Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
59 North America Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
60 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
61 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
62 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
63 North America Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
64 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
65 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
66 North America Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
67 North America Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
68 North America Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
69 North America Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
70 North America Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
71 North America Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
72 North America Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
73 North America Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
74 North America Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
75 North America Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
76 North America Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
77 North America Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
78 North America Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
79 North America Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
80 North America Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
81 North America Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
82 North America Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
83 North America Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
84 North America Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
85 North America Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
86 North America Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
87 Europe Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
88 Europe Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
89 Europe Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
90 Europe Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
91 Europe Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
92 Europe Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
93 Europe Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
94 Europe Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
95 Europe Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
96 Europe Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
97 Europe Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
98 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
99 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
100 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
101 Europe Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
102 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
103 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
104 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
105 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
106 Europe Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
107 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
108 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
109 Europe Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
110 Europe Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
111 Europe Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
112 Europe Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
113 Europe Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
114 Europe Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
115 Europe Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
116 Europe Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
117 Europe Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
118 Europe Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
119 Europe Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
120 Europe Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
121 Europe Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
122 Europe Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
123 Europe Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
124 Europe Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
125 Europe Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
126 Europe Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
127 Europe Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
128 Europe Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
129 Europe Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
130 Asia Pacific Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
131 Asia Pacific Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
132 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
133 Asia Pacific Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
134 Asia Pacific Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
135 Asia Pacific Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
136 Asia Pacific Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
137 Asia Pacific Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
138 Asia Pacific Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
139 Asia Pacific Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
140 Asia Pacific Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
141 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
142 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
143 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
144 Asia Pacific Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
145 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
146 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
147 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
148 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
149 Asia Pacific Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
150 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
151 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
152 Asia Pacific Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
153 Asia Pacific Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
154 Asia Pacific Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
155 Asia Pacific Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
156 Asia Pacific Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
157 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
158 Asia Pacific Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
159 Asia Pacific Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
160 Asia Pacific Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
161 Asia Pacific Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
162 Asia Pacific Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
163 Asia Pacific Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
164 Asia Pacific Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
165 Asia Pacific Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
166 Asia Pacific Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
167 Asia Pacific Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
168 Asia Pacific Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
169 Asia Pacific Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
170 Asia Pacific Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
171 Asia Pacific Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
172 Asia Pacific Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)
173 RoW Nuclear Medicine Market Outlook, By Country (2013-2022) ($MN)
174 RoW Nuclear Medicine Market Outlook, By Application (2013-2022) ($MN)
175 RoW Nuclear Medicine Market Outlook, By Therapeutics (2013-2022) ($MN)
176 RoW Nuclear Medicine Market Outlook, By Bone Metastasis (2013-2022) ($MN)
177 RoW Nuclear Medicine Market Outlook, By Endocrine Tumors (2013-2022) ($MN)
178 RoW Nuclear Medicine Market Outlook, By Lymphoma (2013-2022) ($MN)
179 RoW Nuclear Medicine Market Outlook, By Thyroid (2013-2022) ($MN)
180 RoW Nuclear Medicine Market Outlook, By Nephrology (2013-2022) ($MN)
181 RoW Nuclear Medicine Market Outlook, By Cardiology (2013-2022) ($MN)
182 RoW Nuclear Medicine Market Outlook, By Neurology (2013-2022) ($MN)
183 RoW Nuclear Medicine Market Outlook, By Other Therapeutic Applications (2013-2022) ($MN)
184 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
185 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) (2013-2022) ($MN)
186 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
187 RoW Nuclear Medicine Market Outlook, By Type (2013-2022) ($MN)
188 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine Therapeutic Isotopes (2013-2022) ($MN)
189 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
190 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
191 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
192 RoW Nuclear Medicine Market Outlook, By Nuclear Medicine/Radiopharmaceuticals Diagnostics (2013-2022) ($MN)
193 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
194 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) (2013-2022) ($MN)
195 RoW Nuclear Medicine Market Outlook, By Procedural Volume (2013-2022) ($MN)
196 RoW Nuclear Medicine Market Outlook, By Therapeutic (2013-2022) ($MN)
197 RoW Nuclear Medicine Market Outlook, By Alpha Emitters (2013-2022) ($MN)
198 RoW Nuclear Medicine Market Outlook, By Beta Emitters (2013-2022) ($MN)
199 RoW Nuclear Medicine Market Outlook, By Brachytherapy (2013-2022) ($MN)
200 RoW Nuclear Medicine Market Outlook, By Diagnostics (2013-2022) ($MN)
201 RoW Nuclear Medicine Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2013-2022) ($MN)
202 RoW Nuclear Medicine Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2013-2022) ($MN)
203 RoW Nuclear Medicine Market Outlook, By End User (2013-2022) ($MN)
204 RoW Nuclear Medicine Market Outlook, By Academic Research Laboratories (2013-2022) ($MN)
205 RoW Nuclear Medicine Market Outlook, By Industries (2013-2022) ($MN)
206 RoW Nuclear Medicine Market Outlook, By Medical (2013-2022) ($MN)
207 RoW Nuclear Medicine Market Outlook, By Hospitals (2013-2022) ($MN)
208 RoW Nuclear Medicine Market Outlook, By Diagnostic Centers (2013-2022) ($MN)
209 RoW Nuclear Medicine Market Outlook, By Stable Isotope (2013-2022) ($MN)
210 RoW Nuclear Medicine Market Outlook, By Sulphur (S-32) (2013-2022) ($MN)
211 RoW Nuclear Medicine Market Outlook, By Oxygen (O-18) (2013-2022) ($MN)
212 RoW Nuclear Medicine Market Outlook, By Nitrogen (N-15) (2013-2022) ($MN)
213 RoW Nuclear Medicine Market Outlook, By Deuterium (D2) (2013-2022) ($MN)
214 RoW Nuclear Medicine Market Outlook, By Carbon (C-13) (2013-2022) ($MN)
215 RoW Nuclear Medicine Market Outlook, By Other stable isotopes (2013-2022) ($MN)


【レポート販売概要】

■ タイトル:核医学の世界市場2015-2022
■ 英文:Nuclear Medicine - Global Market Outlook (2015-2022)
■ 発行日:2016年6月19日
■ 調査会社:Stratistics MRC
■ 商品コード:SMRC60765
■ 調査対象地域:グローバル
  • インドの商用車用テレマチックス市場2016-2020
    About Telematics System The telematics system in a vehicle is a device that deals with communication (sending, receiving, and storing information) regarding the vehicle and other parameters. The telematics system collects information from different on-board sensors, such as vehicle speed, braking system, advanced driver assistance system (ADAS), air bags, transmission control system, and many othe …
  • 世界の睡眠時無呼吸症候群治療市場動向(~2020)
    Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in t …
  • TS-1:大腸癌治療薬市場分析
    TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthc …
  • 医薬品添加物の世界市場:リン酸カルシウム、炭酸カルシウム、硫酸カルシウム、岩塩、金属酸化物、糖質、グリコール、ポビドン、鉱物系炭化水素等
    Pharmaceutical excipients are inactive ingredients used along with the active ingredients in a drug formulation. While excipients may have different functionalities, they generally do not affect the therapeutic action of the active ingredient. The demand for functional excipients is expected to record a strong growth in the forecast period due to its increased use in advanced drug delivery forms. …
  • 世界のデータセンターVOD市場動向(2012-2016)
    TechNavio's analysts forecast the Global Data Center Video on Demand (VOD) market to grow at a CAGR of 13.87 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for HD programming and on-demand content. The Global Data Center VOD market has also been witnessing innovation in server technology. However, inefficient streaming of VOD c …
  • バルブのグローバル市場(~2019)
    The industry report Global Valve Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for valves in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, …
  • 世界の小売産業IT支出市場動向(2012-2016)
    TechNavio's analysts forecast the Global Retail Industry IT Spending market to grow at a CAGR of 4.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need to adopt customer-centric technology. The Global Retail Industry IT Spending market has also been witnessing an increased adoption of cloud services. However, data security concerns cou …
  • 大腸癌の対外診断用スクリーニング検査:企業と競争環境
    MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players Summary GlobalData has released its medical device report, “MediPoint: In-Vitro Colorectal Cancer Screening Tests - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the steadily growing In-Vitro Colorectal Cancer Screening Tests Market. Co …
  • China Huaneng Group:発電所及び企業SWTO分析2015
    China Huaneng Group - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and …
  • 世界のMEMS市場動向
    Benefited by the introduction of MEMS (Micro Electromechanical Systems) onto consumer electronic devices like smartphones and tablets, the worldwide MEMS market has entered the high growth phase. MEMS often encompass accelerometers, gyroscopes, and microphones. Most importantly, MEMS have the same equipment and standard processes utilized in the semiconductor industry and therefore have sparked in …
  • 高圧電力ケーブルの世界市場:架空電力ケーブル、地下電力ケーブル、海底電力ケーブル
    About Power Cable A power cable is an insulated strand of wires used to transmit electricity at variable voltage levels. It is mainly used in overhead lines, buildings, and underground wiring applications to transmit electricity. It is available in different sizes and shapes according to the requirements of industries such as telecommunication, electrical equipment, construction, and motor vehicle …
  • コンクリートおよびセメントの世界市場2016-2020
    About Concrete and Cement Concrete has high compressive strength, resisting corrosive, and weathering effects. Different types of concrete are high-density concrete, lightweight concrete, pre-packed concrete, RMC, and shotcrete. The revival of the global construction sector during 2011-2015 contributed to the global concrete market in terms of increased investments. It also has led to a heightened …
  • ビデオ監視の世界市場:システム(アナログ、IP)、構成品(カメラ、モニター、サーバー、ストレージデバイス、ソフトウェア)、サービス(VSaaS、メンテナンス)、用途、地域別分析
    The video surveillance market is expected to be worth USD 71.28 Billion by 2022, at an estimated CAGR of 16.56%. It holds a great potential across the commercial sector. This system is used to monitor the changing activities, changing information to protect, manage, and direct people. The commercial sector accounted for the largest share among all applications of the video surveillance market, fol …
  • Occidental Petroleum Corporation社の石油・ガス開発・生産動向及びコスト分析(2013年)
    Occidental Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Occidental Petroleum Corporation (Oxy) is an international oil and gas exploration and production company. It gathers treats, processes, transports, stores, purchases and sells oil, natural gas, condensate, natural gas liquids, carbon dioxide and power. It also manufactures chemical pr …
  • 2014年戦略提言:アメリカの薬物乱用検査市場
    This new 262-page report from Venture Planning Group provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.  The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepress …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。